ICON plc’s Post

Want an inside view of the changing face of oncology development? Get your free insights in partnership with IQVIA now: https://ow.ly/1OlI50Sq4yE. Download your free insight brief now to learn more about: • The current dose selection paradigm in oncology clinical trials • Dose optimization for better clinical trial outcomes • Patient-centricity and patient diversity • Complexity in combination therapies ... and more! #OncologyDevelopment #IQVIA #OncologyResearch #ClinicalResearch

Want an inside view of the changing face of oncology development? Get your free insights in partnership with IQVIA now: https://ow.ly/RNGl50SpqRO. Download your free insight brief now to learn more about: • The current dose selection paradigm in oncology clinical trials • Dose optimization for better clinical trial outcomes • Patient-centricity and patient diversity • Complexity in combination therapies ... and more! #OncologyDevelopment #IQVIA #OncologyResearch #ClinicalResearch

Developing an oncology treatment? A holistic, strategic plan from the start is key for success. Take a look at our recent blog that explores considerations for clinical trials, real-world data, and navigating a global landscape. https://lnkd.in/e8azDXJ4 #clinicaltrials #research #drugdevelopment Fortrea

Is your #eCOA built to navigate the complexities of oncology research? Discover key insights and recommendations on how to optimize your clinical trial tech in our oncology infographic here: https://hubs.ly/Q02H5M_f0

Developing an oncology treatment? A holistic, strategic plan from the start is key for success. Fortrea's blog explores considerations for clinical trials, real-world data, and navigating a global landscape. https://lnkd.in/dqeMG833 #clinicaltrials #research #drugdevelopment

Inadequate CRA training for oncology clinical trials can lead to a host of challenges that can make or break your study outcome. Discover how to ensure your trials are led by well-equipped experts with guidance from our latest white paper: https://bit.ly/3BULUf5

In the next blog in our oncology series, Parexel experts outline a proven 4-part approach to understanding and integrating the patient perspective and how it can guide study design and improve outcomes. Our dedicated team of Biotech experts will amplify your team’s expertise to help you uncover insights faster to impact patient lives. Let’s change lives together. #OncologyResearch #PatientPerspective #ClinicalTrials #ParexelBiotech

In the next blog in our oncology series, Parexel experts outline a proven 4-part approach to understanding and integrating the patient perspective and how it can guide study design and improve outcomes. Our dedicated team of Biotech experts will amplify your team’s expertise to help you uncover insights faster to impact patient lives. Let’s change lives together. #OncologyResearch #PatientPerspective #ClinicalTrials #ParexelBiotech

When considering Clinical Research Organizations (CROs) for oncology trials, what's the top priority for you? 💡 Oncology Expertise and Experience 💡 Access to Cutting-edge Technology and Treatments 💻 💡 Patient-Centric Approach and Support 💡 Quality of life 💡 Comprehensive Regulatory Knowledge and Compliance 📜 Comment the factor that holds the most significance in your oncology research endeavors and share your insights! #OncologyResearch #CROPriorities

Developing an oncology treatment? A holistic, strategic plan from the start is key for success. Fortrea's blog explores considerations for clinical trials, real-world data, and navigating a global landscape. https://lnkd.in/ggX9mGUC #clinicaltrials #research #drugdevelopment